IL10 and neoplasm: WNT5a can also specifically activate the TLR/MyD88/p50 pathway in bone marrow monocytes and promote the synthesis of anti-inflammatory cytokines such as IL-10 and the tolerance phenotype, thus forming an immunosuppressive tumor microenvironment [36].